📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Tumour cell responses to new fibroblast growth factor receptor tyrosine kinase inhibitors and identification of a gatekeeper mutation in FGFR3 as a mechanism of acquired resistance. (2013)

First Author: Chell V

Attributed to: A systems approach to understanding lipid, Ca2+ and MAPK signalling networks funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/onc.2012.319

PubMed Identifier: 22869148

Publication URI: http://europepmc.org/abstract/MED/22869148

Type: Journal Article/Review

Volume: 32

Parent Publication: Oncogene

Issue: 25

ISSN: 0950-9232